Management of Takotsubo Syndrome: A Comprehensive Review.

acute coronary syndrome cardiomyopathy left ventricular outflow tract obstruction takotsubo cardiomyopathy takotsubo syndrome

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
03 Jan 2020
Historique:
entrez: 12 2 2020
pubmed: 12 2 2020
medline: 12 2 2020
Statut: epublish

Résumé

Takotsubo syndrome (TTS), also known as Takotsubo cardiomyopathy, is a transient left ventricular wall dysfunction that is often triggered by physical or emotional stressors. Although TTS is a rare disease with a prevalence of only 0.5% to 0.9% in the general population, it is often misdiagnosed as acute coronary syndrome. A diagnosis of TTS can be made using Mayo diagnostic criteria. The initial management of TTS includes dual antiplatelet therapy, anticoagulants, beta-blockers, angiotensin-converting enzyme inhibitors or aldosterone receptor blockers, and statins. Treatment is usually provided for up to three months and has a good safety profile. For TTS with complications such as cardiogenic shock, management depends on left ventricular outflow tract obstruction (LVOTO). In patients without LVOTO, inotropic agents can be used to maintain pressure, while inotropic agents are contraindicated in patients with LVOTO. In TTS with thromboembolism, heparin should be started, and patients should be bridged to warfarin for up to three months to prevent systemic emboli. Our comprehensive review discussed the management in detail, derived from the most recent literature from observational studies, systematic review, and meta-analyses.

Identifiants

pubmed: 32042529
doi: 10.7759/cureus.6556
pmc: PMC6996473
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e6556

Informations de copyright

Copyright © 2020, Sattar et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Neth Heart J. 2016 Sep;24(9):511-9
pubmed: 27401602
Int J Cardiol. 2008 Jun 23;127(1):121-3
pubmed: 17544159
Int J Cardiol. 2012 Feb 9;154(3):e54-6
pubmed: 21703695
Int J Cardiol. 2010 May 14;141(1):11-7
pubmed: 19913310
Circulation. 2005 Feb 1;111(4):472-9
pubmed: 15687136
Eur Heart J. 2016 Oct 1;37(37):2816-2820
pubmed: 26966148
J Cardiol. 2016 Feb;67(2):153-61
pubmed: 26347218
Ann Intern Med. 2004 Dec 7;141(11):858-65
pubmed: 15583228
Acta Clin Belg. 2011 Jul-Aug;66(4):298-301
pubmed: 21938986
Arch Cardiovasc Dis. 2016 Jan;109(1):4-12
pubmed: 26507532
BMC Cardiovasc Disord. 2014 Oct 22;14:147
pubmed: 25339604
Am Heart J. 2008 Mar;155(3):408-17
pubmed: 18294473
Int J Cardiol. 2014 Jul 1;174(3):696-701
pubmed: 24809923
BMC Cardiovasc Disord. 2018 Jul 11;18(1):144
pubmed: 29996761
Clin Cardiol. 2011 Nov;34(11):672-6
pubmed: 21919012
Heart. 2016 Jul 1;102(13):1029-35
pubmed: 26879240
Clin Cardiol. 2014 Jul;37(7):434-9
pubmed: 24700369
Cardiovasc Ther. 2013 Dec;31(6):e133-7
pubmed: 24119220
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Eur J Intern Med. 2014 Feb;25(2):132-6
pubmed: 24095653
Circulation. 2005 Feb 1;111(4):388-90
pubmed: 15687123
Int J Cardiol. 2018 Sep 15;267:22-27
pubmed: 29957259
Am J Cardiol. 2009 Apr 1;103(7):1015-9
pubmed: 19327433
Catheter Cardiovasc Interv. 2014 Feb 15;83(3):343-8
pubmed: 22121008
Eur J Heart Fail. 2009 Jul;11(7):721-7
pubmed: 19468019
BMC Cardiovasc Disord. 2018 Mar 20;18(1):54
pubmed: 29554866
Circulation. 2019 Jan 15;139(3):413-415
pubmed: 30586690
Cardiovasc Ther. 2016 Jun;34(3):161-6
pubmed: 26946520
Am Heart J. 2012 Jul;164(1):66-71.e1
pubmed: 22795284
Mayo Clin Proc. 2001 Jan;76(1):79-83
pubmed: 11155418
BMC Cardiovasc Disord. 2017 Aug 17;17(1):225
pubmed: 28818058
JACC Heart Fail. 2018 Nov;6(11):928-936
pubmed: 30316938
J Am Heart Assoc. 2017 Dec 4;6(12):
pubmed: 29203578
Heart Vessels. 2016 Aug;31(8):1285-90
pubmed: 26266632
Congest Heart Fail. 2011 Jan-Feb;17(1):38-41
pubmed: 21272226
Clin Cardiol. 2013 Jul;36(7):401-6
pubmed: 23585361
Chest. 2007 Sep;132(3):809-16
pubmed: 17573507
JAMA. 2011 Jul 20;306(3):277-86
pubmed: 21771988

Auteurs

Yasar Sattar (Y)

Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.

Kelvin Shenq Woei Siew (KSW)

Cardiology, University of Malaya, Kuala Lumpur, MYS.

Michael Connerney (M)

Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.

Waqas Ullah (W)

Internal Medicine, Abington Hospital - Jefferson Health, Abington, USA.

M Chadi Alraies (MC)

Cardiology, Detroit Medical Center, Detroit, USA.

Classifications MeSH